These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31925706)

  • 1. Decreased mRNA Expressions of CD40L in Patients with Neuromyelitis Optica Spectrum Disorder.
    Shi Z; Feng L; Lian Z; Liu J; Chen H; Du Q; Zhang Y; Zhang Q; Yang M; Zhou H
    J Mol Neurosci; 2020 Apr; 70(4):610-617. PubMed ID: 31925706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon Regulatory Factor 5 Gene Polymorphisms and mRNA Expression Levels Are Associated with Neuromyelitis Optica Spectrum Disorder.
    Wang G; Jing L; Wang Y; Mehmood A; Zhang H; Guo R; Zhang L; Li B
    Mol Neurobiol; 2024 Oct; 61(10):7989-7999. PubMed ID: 38451436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of the membrane-bound CD40 ligand on peripheral CD4
    Liu J; Zhang Q; Shi Z; Yang M; Lian Z; Chen H; Feng H; Du Q; Zhang Y; Miao X; Li H; Zhou H
    J Neuroimmunol; 2018 Dec; 325():64-68. PubMed ID: 30408708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased frequency of IL-6-producing non-classical monocytes in neuromyelitis optica spectrum disorder.
    Kong BS; Kim Y; Kim GY; Hyun JW; Kim SH; Jeong A; Kim HJ
    J Neuroinflammation; 2017 Sep; 14(1):191. PubMed ID: 28946890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BLK polymorphisms and expression level in neuromyelitis optica spectrum disorder.
    Yin BW; Li B; Mehmood A; Yuan C; Song S; Guo RY; Zhang L; Ma T; Guo L
    CNS Neurosci Ther; 2021 Dec; 27(12):1549-1560. PubMed ID: 34637583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foxp3+ regulatory T cells expression in neuromyelitis optica spectrum disorders.
    Brill L; Lavon I; Vaknin-Dembinsky A
    Mult Scler Relat Disord; 2019 May; 30():114-118. PubMed ID: 30771576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased SIRT1 mRNA expression in peripheral blood mononuclear cells from patients with neuromyelitis optica spectrum disorders.
    Zhang L; Xue Y; Yuan C; Du X; Wang X; Guo L; Li B
    Acta Neurol Belg; 2023 Dec; 123(6):2287-2294. PubMed ID: 37294424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis.
    Keller A; Leidinger P; Meese E; Haas J; Backes C; Rasche L; Behrens JR; Pfuhl C; Wakonig K; Gieß RM; Jarius S; Meder B; Bellmann-Strobl J; Paul F; Pache FC; Ruprecht K
    J Neuroinflammation; 2015 Oct; 12():196. PubMed ID: 26521232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of CD40 Gene Polymorphisms with Susceptibility to Neuromyelitis Optica Spectrum Disorders.
    Shi Z; Zhang Q; Chen H; Miao X; Liu J; Lian Z; Feng H; Zhou H
    Mol Neurobiol; 2017 Sep; 54(7):5236-5242. PubMed ID: 27578014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of HLA-DP in patients with neuromyelitis optica spectrum disorders].
    Chang YY; Wang YG; Fan P; Wang JQ; Shu YQ; Li R; Zhong XN; Long L; Zhao ZH; Li CX; Qiu W
    Zhonghua Yi Xue Za Zhi; 2019 Dec; 99(45):3574-3580. PubMed ID: 31826574
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of Genetic Variation in CD40 and CD40L: Relationship with mRNA Relative Expression and Soluble Proteins in Acute Coronary Syndrome.
    Martínez-Fernández DE; Padilla-Gutiérrez JR; Casillas-Muñoz F; Valdés-Alvarado E; Parra-Reyna B; Aceves-Ramírez M; Muñoz-Valle JF; Zalapa Flores U; Chávez Herrera JC; Valle Y
    J Immunol Res; 2019; 2019():8063983. PubMed ID: 31183392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proinflammatory mediator CD40 ligand is increased in the metabolic syndrome and modulated by adiponectin.
    Natal C; Restituto P; Iñigo C; Colina I; Díez J; Varo N
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2319-27. PubMed ID: 18349065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.
    Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH
    Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between serum levels of endothelin-1 and disease severity in patients with neuromyelitis optica spectrum disorders.
    Yi M; Liu MQ; Chou LS; Jiang SM; Zhang LJ; Huang CN; Wang N; Zhang QX; Yang L
    Immunobiology; 2020 May; 225(3):151959. PubMed ID: 32517881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology.
    Fujihara K; Bennett JL; de Seze J; Haramura M; Kleiter I; Weinshenker BG; Kang D; Mughal T; Yamamura T
    Neurol Neuroimmunol Neuroinflamm; 2020 Sep; 7(5):. PubMed ID: 32820020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of lncRNA XIST may promote Th17 differentiation through KDM6A-TSAd pathway in neuromyelitis optica spectrum disorders.
    Guo RY; Song S; Wang JQ; Guo JY; Liu J; Jia Z; Yuan CC; Li B
    Mult Scler Relat Disord; 2023 Aug; 76():104801. PubMed ID: 37315471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccine response in Neuromyelitis Optica Spectrum Disorder.
    Baba C; Kaya E; Ozcelik S; Ozdogar AT; Samadzade U; Cevik S; Calıskan C; Dogan Y; Ozakbas S
    Clin Neurol Neurosurg; 2024 Mar; 238():108152. PubMed ID: 38382130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different roles of soluble CD40 ligand in central nervous system damage.
    Du L; Chang H; Wei Y; Zhang X; Yin L
    Neurol Res; 2020 May; 42(5):372-378. PubMed ID: 32178599
    [No Abstract]   [Full Text] [Related]  

  • 19. Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica.
    Wilson R; Makuch M; Kienzler AK; Varley J; Taylor J; Woodhall M; Palace J; Leite MI; Waters P; Irani SR
    Brain; 2018 Apr; 141(4):1063-1074. PubMed ID: 29447335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The differential expression of natural killer cells in NMOSD and MS.
    Ding J; Zhu DS; Hong RH; Wu YF; Li ZZ; Zhou XJ; Cai J; Guan YT
    J Clin Neurosci; 2020 Jan; 71():9-14. PubMed ID: 31864829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.